As a result, they suggest that PLG supports the role of the Hippo signaling pathway in the survival of HBV-HCC cells by up-regulating and activating the expression of SRC, hence boosting HBV-induced HCC progression [21]. The gene discussed is PLG; the disease is hepatocellular carcinoma.